Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.

Oncology reports - 1 May 2012

Zhang Ye, Wei Jishu, Wang Hui, Xue Xiaofeng, An Yong, Tang Dong, Yuan Zhongxu, Wang Feitong, Wu Junli, Zhang Jingjing, Miao Yi

Abstract excerpt

The epithelial-mesenchymal transition (EMT) has been linked to induction of a stem-cell like phenotype, characterized by altered cell surface marker expression and increased tumor formation. The aim of this study was to investigate whether EMT correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer. The morphology of untreated and gemcitabine-treated SW1990...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Cadherins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to CD24 Antigen

Share to Epithelial-Mesenchymal Transition

Share to Hyaluronan Receptors

Share to Immunophenotyping

Share to Transcription Factor RelA

Source

Identifiers

PMID: 22322379
DOI: 10.3892/or.2012.1681

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.PMID 22322379Read ↗

Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotypeSemantic proximity Read ↗

Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.Semantic proximity Read ↗

Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem CellsSemantic proximity Read ↗

Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic PropensitiesSemantic proximity Read ↗

miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancerSemantic proximity Read ↗

S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabineSemantic proximity Read ↗

Epithelial and Mesenchymal Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Being Associated with Different Metastatic PropensitySemantic proximity Read ↗

Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.Semantic proximity Read ↗

Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer.Semantic proximity Read ↗

MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell RenewalSemantic proximity Read ↗

p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling.Semantic proximity Read ↗

MiR-1301-3p Inhibits Epithelial to Mesenchymal Transition via Targeting RhoA in Pancreatic CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.